In a recent study published in Frontiers in Immunology, researchers investigated the use of herring row oil to treat psoriasis, a non-communicable skin disease. Conventional psoriasis treatment, while effective, is prone to several side effects, necessitating the discovery of novel side-effect-free interventions.
Study: Herring roe oil in treatment of psoriasis – influence on immune cells and cytokine network. Image Credit: Mady MacDonald/Shutterstock.com
The results of this study identify herring roe oil as a potential future psoriasis therapy, with the oil observed to cause numerous beneficial modifications in cytokine networks and immune cells of individuals afflicted by the condition.
Psoriasis
Psoriasis is a non-communicable, immune-mediated, lifelong skin disease characterized by rashes with itchy, scaly patches, most commonly on the knees, elbows, trunk, and scalp. Psoriasis in populations can vary widely in severity, with even the same individual depicting variable disease symptoms throughout their lives.
The condition is estimated to affect 125 million people globally, with no cure currently available. Psoriasis is associated with numerous co-morbidities, including cardiometabolic diseases, psoriatic arthritis, gastrointestinal diseases, chronic kidney disease, and psychosocial disorders.
Conventional, severity-specific treatments for the condition remain primarily topical, intended to suppress the immune response and control symptoms. While novel systemic treatments biologicals have benefitted patients suffering from severe disease manifestations, 80% of patients with mild to moderate psoriasis present low medication adherence due to topical agents being prone to harmful side effects.
Recently, research has investigated omega-3 polyunsaturated fatty acids (ω3-PUFA), biomolecules commonly found in fish and seafood with